Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Interest Expense : ₫ Mil (TTM As of . 20)

View and export this data going back to 2009. Start your Free Trial

What is Pharmedic Pharmaceutical Medicinal Joint Stock Company Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Pharmedic Pharmaceutical Medicinal Joint Stock Company's interest expense for the three months ended in . 20 was ₫ 0.00 Mil. Pharmedic Pharmaceutical Medicinal Joint Stock Company does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Pharmedic Pharmaceutical Medicinal Joint Stock Company's Operating Income for the three months ended in . 20 was ₫ 0.00 Mil. Pharmedic Pharmaceutical Medicinal Joint Stock Company's Interest Expense for the three months ended in . 20 was ₫ 0.00 Mil. Pharmedic Pharmaceutical Medicinal Joint Stock Company did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Interest Expense Historical Data

The historical data trend for Pharmedic Pharmaceutical Medicinal Joint Stock Company's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmedic Pharmaceutical Medicinal Joint Stock Company Interest Expense Chart

Pharmedic Pharmaceutical Medicinal Joint Stock Company Annual Data

Trend

Interest Expense

Pharmedic Pharmaceutical Medicinal Joint Stock Company Quarterly Data

Interest Expense

Pharmedic Pharmaceutical Medicinal Joint Stock Company Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Interest Expense for the three months ended in . 20 was ₫0.00 Mil. Its Operating Income for the three months ended in . 20 was ₫0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in . 20 was ₫0.00 Mil.

Pharmedic Pharmaceutical Medicinal Joint Stock Company's Interest Coverage for the quarter that ended in . 20 is calculated as

Pharmedic Pharmaceutical Medicinal Joint Stock Company had no long-term debt ⁽¹⁾.

The higher the ratio, the stronger the company's financial strength is.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

367 Nguyen Trai, Nguyen Cu Trinh Ward, District 1, TP. HCM, Ho Chi Minh, VNM

Website

https://www.pharmedic.com.vn

Pharmedic Pharmaceutical Medicinal Joint Stock Company is involved in the production and sales of pharmaceutical products, pharmaceuticals, cosmetics, medical supplies, and other products in the health sector.

Pharmedic Pharmaceutical Medicinal Joint Stock Company (HSTC:PMC) Headlines

From GuruFocus

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 08-05-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor • 11-16-2009

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor • 08-13-2010

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk • 11-04-2010

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk • 06-25-2012